{
  "id": "60259fe91cb411341a0000b3",
  "type": "yesno",
  "question": "Is tocilizumab a csDMARD?",
  "ideal_answer": "No, tocilizumab is a biological DMARD (bDMARD).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31969328"
  ],
  "snippets": [
    {
      "text": "The task force agreed on 5 overarching principles and 12 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate (MTX), leflunomide, sulfasalazine); glucocorticoids (GCs); biological (b) DMARDs (tumour necrosis factor inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab), abatacept, rituximab, tocilizumab, sarilumab and biosimilar (bs) DMARDs) and targeted synthetic (ts) DMARDs (the Janus kinase (JAK) inhibitors tofacitinib, baricitinib, filgotinib, upadacitinib). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31969328",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}